These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 11726216

  • 1. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI, Konttinen Y, Fisher A.
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [Abstract] [Full Text] [Related]

  • 2. Approaches to the treatment of Sjögren's syndrome.
    Fox RI, Michelson P.
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The therapy of Sjogren's syndrome: a review.
    Coaccioli S, Giuliani M, Puxeddu A.
    Clin Ter; 2007 Dec; 158(5):453-6. PubMed ID: 18062353
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P.
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [Abstract] [Full Text] [Related]

  • 9. Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
    Nishimura H, Yakeishi A, Saga T, Yamaki K.
    Kurume Med J; 2009 Mar; 56(3-4):39-47. PubMed ID: 20505281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
    Arisawa H, Imai E, Fujise N, Fukui K, Masunaga H.
    Arzneimittelforschung; 2002 Mar; 52(1):14-20. PubMed ID: 11838269
    [Abstract] [Full Text] [Related]

  • 12. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, Yamane T, Murata M, Tsumiyama K, Hashiramoto A, Shiozawa S.
    Mod Rheumatol; 2009 Mar; 19(4):416-9. PubMed ID: 19452244
    [Abstract] [Full Text] [Related]

  • 13. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
    Nakamura M, Saga T, Watanabe K, Takahashi N, Tabira Y, Kusukawa J, Yamaki K.
    Kurume Med J; 2013 Mar; 60(1):7-19. PubMed ID: 23925155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
    Rhodus NL.
    Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis on pharmacological therapies in the management of xerostomia in patients with Sjogren's syndrome.
    Garlapati K, Kammari A, Badam RK, B E S, Boringi M, Soni P.
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):312-318. PubMed ID: 30932714
    [Abstract] [Full Text] [Related]

  • 17. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
    Arisawa H, Fukui K, Fujise N, Masunaga H.
    Arzneimittelforschung; 2002 Apr; 52(2):81-8. PubMed ID: 11878203
    [Abstract] [Full Text] [Related]

  • 18. [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
    Nishinarita M, Hanzawa M, Iikuni N, Ota S.
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):99-102. PubMed ID: 15164930
    [Abstract] [Full Text] [Related]

  • 19. Sjögren's syndrome comes of age.
    Anaya JM, Talal N.
    Semin Arthritis Rheum; 1999 Jun; 28(6):355-9. PubMed ID: 10406403
    [No Abstract] [Full Text] [Related]

  • 20. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
    von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiødt M.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.